Inhibitory effects of puerarin on cytochrome P450 subfamilies in vitro

Oriental Pharmacy and Experimental Medicine

Volumn 14, Issue 1, 2014, Pages 1-5

  Kim, Jong Yoon ^a   Kim, Jin Sook ^b   Jung, Ji Hyun ^a   Chun, Pusoon ^c   Rhew, Ki Yon ^a  

^a Dongduk Women's University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c Inje University   (South Korea)

Author keywords

Cytochrome P450; Fluorescent substrate; High throughput screening (HTS); Puerarin

Indexed keywords

ALPHA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; MICONAZOLE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE HYDROGEN P450; PUERARIN; QUINIDINE; RECOMBINANT CYTOCHROME P450; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; COMMON COLD; ENZYME INHIBITION; HERB DRUG INTERACTION; HERBAL MEDICINE; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 84896076225     PISSN: 15982386     EISSN: 22111069     Source Type: Journal    
DOI: 10.1007/s13596-013-0138-y     Document Type: Article

References (20)

1. Capdevila JH, Zeldin D, Makita K, Karara A, Falck JR (1995) Cytochrome P450 and the metabolism of arachidonic acid and oxygenated eicosanoids. In: Paul R (ed) Cytochrome P450: structure, mechanism and biochemistry, 2nd edn. Ortiz de Montellano Plenum Press, New York, pp 443-472.
2. Ernst E (2002) The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136: 42-53.
3. Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286: 487-491.
4. Guengerich FP (1995) Human cytochrome P450 enzymes. In: Paul R (ed) Cytochrome P450: structure, mechanism and biochemistry, 2nd edn. Ortiz de Montellano Plenum Press, New York, pp 473-536.
5. Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21: 70-83.
6. Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghett A, Crespi-Perellino N, Mirasoli M, Cantelli-Forti G, Paolini M (2000) Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci 67: 2997-3006.
7. Kim KI, Kim SH, Park JE, Chae HJ, Choi JS, Shin WG, Son IJ, Oh JM (2006) Clinical pharmacogenomics of drug metabolizing enzymes and its clinical application. Kor J Clin Pharm 16: 155-164.
8. Lee SJ, Lee YJ (2012) Use of dietary supplements and their interactions with prescription drugs in the elderly with chronic diseases in a community pharmacy. Kor J Clin Pharm 22: 347-355.
9. Marks BD, Smith RW, Braun HA, Goossens TA, Christenson M, Ozers MS, Lebakken CS, Trubetskoy OV (2002) A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic Vivid P450 substrate. ASSAY Drug Devel Technol 1: 73-81.
10. Marks BD, Goossens TA, Braun HA, Ozers MS, Smith RW, Lebakken C, Trubetskoy OV (2003) High-throughput screening assays for CYP2B6 metabolism and inhibition using fluorogenic vivid substrates. AAPS PharmSci 5: 88-98.
11. Ock SM, Choi JY, Cha YS, Lee JB, Chun MS, Huh CH, Lee SY, Lee SJ (2009) The use of complementary and alternative medicine in a generalpopulation in South Korea: results from a National Survey in 2006. J Korean Med Sci 24: 1-6.
12. Oh JM, Kim BH (2008) Hepatic expression of drug metabolizing enzyme in diabetes. J Environ Toxicol 23: 165-170.
13. Okoro CA, Zhao G, Li C, Balluz LS (2013) Has the use of complementary and alternative medicine therapies by U. S. adults with chronic disease-related functional limitations changed from 2002 to 2007? J Altern Complement Med 19: 217-223.
14. Pharmacopoeia of the People's Republic of China, PPRC (2005) Radix Puerariae Lobatae. Prople's Medical Publishing House, Beijing, p 230.
15. Reppert A, Yousef GG, Rogers RB, Lila MA (2008) Isolation of radiolabeled isoflavones from Kudzu (Puerarialobata) root cultures. J Agric Food Chem 56: 7860-7865.
16. Saxena A, Tripathi KP, Roy S, Khan F, Sharma A (2008) Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450. Bioinformation 3: 198-204.
17. Tu ZL, Zhang C, Cheng XL, Wang QB, Zhang PH (2007) Effects of puerarin on the activities of 5 cytochrome P_(450)s in vitro. Herald Med 26: 852-856.
18. Wang LS, Zhu B, Abd El-Aty AM, Zhou G, Li Z, Wu J, Chen GL, Liu J, Tang ZR, An W, Li Q, Wang D, Zhou HH (2004) The influence of St John's Wort on CYP2C19 activity with respect to genotype. J Clin Pharmacol 44: 577-581.
19. Wong KH, Li GQ, Li KM, Razmovski-Naumovskia V, Chan K (2011) Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol 134: 584-607.
20. Zheng J, Chen B, Jiang B, Zeng L, Tang ZR, Fan L, Zhou HH (2010) The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. Arch Pharm Res 33: 243-246.